Hodgkin Lymphoma, Adult Clinical Trial
Official title:
Cardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors
SURVIVORS Study participants are being asked to take part in this research study called HODNIRS because the participant is a survivor of Hodgkin Lymphoma (HL) treated with chest radiation and bleomycin at St. Jude Children's Research Hospital. The study is being done to help investigators understand the link between long term effects of chest radiation and bleomycin for HL and brain function in survivors. Primary Objective To evaluate dynamic changes in CBF and oxygenation during exercise with Near Infrared Spectroscopy (NIRS) in HL survivors and non-cancer controls matched for age, sex, race, and ethnicity. . Secondary Objectives To examine the degree of CO2 clearance (DLCO/ETCO2) during rest and exercise in Hodgkin Lymphoma (HL) survivors compared to non-cancer controls matched for age, sex, race, and ethnicity. CONTROLS Volunteers are being asked to take part in this research study because they are non-first degree relative or friend of someone who received treatment for a childhood cancer or similar illness at St. Jude Children's Research Hospital or are an employee/affiliate of St. Jude Children's Research Hospital and have agreed to be a St. Jude Life Cohort Study (SJLIFE) community control.
NIRS is a portable, non-invasive, brain imaging device that uses low levels of non-ionizing light to record variations in blood flow in the brain. The NIRS is wearable and can read blood flow to the brain during physical activity. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04653649 -
CAR T-cells Against CD30 (HSP-CAR30) for Relapsed/ Refractory Hodgkin and T-cell Lymphoma.
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04636255 -
Physical Capacity in Hodgkin Lymphoma Survivors
|
N/A | |
| Recruiting |
NCT05597761 -
Immunogenicity of COVID-19 Vaccination in Autologous HSCT or CAR-T Cells Recipients
|
||
| Active, not recruiting |
NCT03535948 -
Elderly Hodgkin Lymphoma Patients Treated With Chemoradiotherapy
|
||
| Completed |
NCT03155425 -
PD-1 Antibody SHR-1210 in Patients With Relapsed or Refractory Classic Hodgkin's Lymphoma
|
Phase 2 | |
| Recruiting |
NCT03260101 -
Non-interventional, Long-term Follow-up of Subjects Who Completed ApoGraft-01 Study
|
||
| Recruiting |
NCT04776265 -
RWE of Brentuximab Vedotin Consolidation in Patients With RR HL Who Receive Salvage Chemotherapy and ASCT
|
||
| Recruiting |
NCT04378647 -
BREntuximab Vedotin in SEcond LIne Therapy BEfore Transplant
|
Phase 2 | |
| Recruiting |
NCT04758650 -
Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions, Cardiovascular Atherosclerosis, Syndrome With Abnormal Immune Activation and sarcoïdosis
|
Phase 2 | |
| Recruiting |
NCT05137886 -
PD-1 Inhibitor Combined With Decitabine Followed by ASCT as Second-line Therapy for Relapsed or Refractory Classic Hodgkin's Lymphoma
|
Phase 2 | |
| Recruiting |
NCT05798897 -
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
|
Phase 1 | |
| Completed |
NCT04292626 -
Molecular Imaging of Lymphoma Using Labeled Technetium-99m 1-Thio-D-Glucose
|
Phase 1 | |
| Active, not recruiting |
NCT04268706 -
Phase 2 Study Evaluating Autologous CD30.CAR-T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma (CHARIOT)
|
Phase 2 | |
| Recruiting |
NCT04638790 -
First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1)
|
Phase 3 | |
| Completed |
NCT01578967 -
Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma
|
N/A | |
| No longer available |
NCT03914885 -
Compassionate Use Re-Infusion of ATLCAR.CD30
|